Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.42
Delayed Data
As of Aug 18
 -0.02 / -0.82%
Today’s Change
1.65
Today|||52-Week Range
5.70
+39.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line47.7M-24.6M-69.1M-30.5M
 
 
 
 
 
Depreciation1.5M2.0M2.1M2.1M
 
 
 
 
 
Total Other Cash Flow-80.4M-10.8M14.8M-7.3M
 
 
 
 
 
Funds From Operations-31.2M-33.4M-52.2M-35.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-8.5M323.0K-2.2M4.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-22.8M-33.7M-49.9M-40.1M
 
 
 
 
 
 
InvestingIncrease In Investments-50.0K75.0M0.00-90.0M
 
 
 
 
Decrease In Investments19.5M-10.0M1.5M140.0M
 
 
 
 
 
Capital Expenditures0.00-44.0K0.000.00
 
 
Net Assets From Acquisitions 60.0M-63.5M-3.4M0.00
 
 
 
 
Net Cash Flow Investing19.0M61.9M-1.9M50.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction---10.0M-14.0M0.00
 
 
 
Net Proceeds Stock Sale0.0049.0K0.0047.0K
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing0.00-9.9M-14.0M47.0K
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash38.0K-189.0K-14.0K44.0K
 
 
 
 
 
 
Net Change In Cash-3.8M18.3M-65.8M10.0M